Fig. 3.1
Classification of LSTs
The size and type of LSTs are good predictors of invasive cancer, and the proportion of submucosal carcinoma increases with increasing size of flat depressed types. Non-granular LSTs larger than 30 mm were submucosal invasive carcinoma in 60% of cases. In contrast, homogeneous tumors are not associated with submucosal invasive carcinoma, even when they are larger than 30 mm. Generally, large size, depressed phenotype, and large nodules (≥10 mm) are known to be predictive markers of invasive carcinoma in LSTs [5].
In treating LSTs, conventional endoscopic mucosal resection (EMR) or endoscopic piecemeal resection (EPMR) technique can be suitable for homogeneous tumors. It is also recommended that flat elevated or pseudo-depressed or nodular mixed tumors larger than 20 mm, should be managed using endoscopic submucosal dissection (ESD) with en-bloc resection by the experienced endoscopists.
3.2 EPMR vs. ESD
EMR can replace the surgery in the treatment of early colon cancer without lymph node metastasis. Most colorectal polyps can be treated using simple snaring or EMR, although large sessile colorectal tumors exceeding 20 mm can’t be removed by traditional EMR procedure. For these tumors, piecemeal resection is recommended [6]. The merit of piecemeal resection is that it is safe for resecting large sessile polyp . LSTs with granular homogenous type can be safely treated by EPMR, even it is larger than 30 mm. However, the fragmentation of specimens during conventional polypectomy or EMR prevents the evaluation of the resection margin involvement or the depth of tumor invasion, making it difficult to plan further treatment. In addition, any tumor cells remaining after piecemeal polypectomy can grow on the polypectomy scar and invade the submucosal layer more rapidly. Thus care should be used to remove suspicious malignant tumor including pseudo-depressed type LSTs by EPMR [6–8]. ESD introduced to overcome these limitations is now widely used for excising various gastrointestinal tumors, including colorectal tumors. ESD results in higher rates of en-bloc tumor resection, reducing local recurrences and providing more accurate pathologic information for planning further treatment. However, the procedure time is much longer and the complication rate is much higher for ESD than for EMR, limiting the use of ESD in the removal of colorectal tumors [9, 10].
According to several studies reported the outcomes of ESD, en-bloc resection rate is 84.9% (95% CI, 77.8–90.8), curative resection rate is 75.4% (95% CI, 66.7–82.2). A study on the long term outcomes of colorectal ESD found that the local recurrence rate was 2%, and the 3 and 5 year disease free survival rates were 97% and 95%, respectively. Safety outcomes of colorectal ESD are also important, in as much as perforation associated with this procedure was reported in 3.3–20.4%, with tumor size and the presence of fibrosis being independent risk factors for perforation [11–14]. Although many cases showing perforation have been improved with conservative treatment without surgery, using endoscopic clipping, it make to prolonged hospitalization and to need additional treatments.
In summary, both EPMR and ESD techniques can be used for large sessile polyps or LSTs. EPMR technique has merits of safety, ease and demerits of the difficulty of pathologic evaluation, high rates of local recurrences. ESD technique has merits of en-bloc resection, low rate of recurrence and demerits of long operation time, high rates of complications. Thus, ESD should be recommended for LSTs with suspected malignancy or lesions are technically difficult to treat with conventional EMR, and EPMR should be recommended for adenomatous lesions, LSTs with granular homogenous type [12, 15–18].
3.3 Indication of ESD
Basically, all endoscopic treatment is recommended only for lesions diagnosed as non-invasive tumors with a low metastatic potential. The risk factors for lymph node metastasis are poorly differentiated, signet-ring cell, and mucinous adenocarcinoma, massive submucosal invasion, lymphovascular invasion and tumor budding.
Current indications for colorectal ESD include (1) early colorectal cancer, (2) laterally spreading tumors ≥2 cm in diameter, (3) submucosal tumors, and (4) colorectal polyps with fibrosis. In detail, ESD study group in Japan announced the indication of colorectal ESD include LSTs with non-granular pseudo-depressed type, mucosal lesions with fibrosis caused by inflammation or scar change after biopsy, the tumor with underlying ulcerative colitis, recurred tumors after EMR resection, etc. They excluded the size criteria, more than 20 mm, in ESD indication, because depressed-type tumors with less than 20 mm in size can invade submucosal layer. And they also commented the submucosal infiltration of tumors should be shallow (Table 3.1).
Table 3.1
Indications for ESD for colorectal tumorsa
Lesions for which endoscopic en bloc resection is required |
1. Lesions for which en bloc resection with snare EMR is difficult to apply |
LST-NG, particularly LST-NG (PD) |
Lesions showing a VI-type pit pattern |
Carcinoma with shallow T1 (SM) invasion |
Large depressed-type tumors |
Large protruded-type lesions suspected to be carcinomab |
2. Mucosal tumors with submucosal fibrosisc |
3. Sporadic localized tumors in conditions of chronic inflammation such as ulcerative colitis |
4. Local residual or recurrent early carcinomas after endoscopic resection |
3.4 Preoperative Diagnosis
Before procedure, malignant potential and margins should be clearly identified. Tumor morphology including color, unevenness, depression, fold convergence also carefully evaluated. Malignant tumors have the loss of the surface pattern of pits or the structure of micro-vessels. Dye spraying, magnifying endoscopy, narrow band image can be helpful to identifying it. For predicting the malignant polyps, the accuracy of conventional endoscopy is about 80%, and that of chromo-magnifying endoscopy is up to 96–98%. Endoscopic ultrasonography (EUS) is also helpful to diagnose the submucosal invasive cancer, however it is still not popular because the additional equipment is required.
3.5 ESD Instruments
3.5.1 Knifes
Some kinds of knifes are used for ESD treatment of colon tumors. The Dual knife (Olympus Optical Co., Tokyo, Japan) is most commonly used, and also the Flush knife BT (Fujifilm Medical, Tokyo, Japan) and the Jet B-knife (ZeonMedical, Tokyo, Japan) which are capable of injecting the submucosa solution, are used for colorectal ESD. A notable characteristic of the Jet B-knife is the use of the bipolar current system—it can minimize the damage to the muscle layer and reduce the risk of perforation. The Insulated tip knife-nano (IT-nano, Olympus Optical Co.) has also been developed and have been utilized in colorectal ESD, which has a merit of bringing out the relatively fast treatment. The Hook knife (Olympus Optical Co.) can be used to lift and cut the tissues in cases of the LSTs with fibrosis or the difficult-to-reach tumors. And recently, the clutch cutter (Fujifilm Corp., Tokyo, Japan) of grasping-type scissor forceps and the SB knife Jr. (Sumitomo Bakelite Co., Tokyo, Japan) has been developed and used (Fig. 3.2).
Fig. 3.2
Various endoscopic knives
3.5.2 Hemostatic Forceps
The Hemostat-Y (H-S2518; Pentax) of a bipolar-type hemostatic Forceps and the Coagrasper (FD-410LR; Olympus Medical Systems Co., Tokyo, Japan) of a monopolar-type forceps have been currently used in ESD procedures.
3.5.3 Distal Attachments
Various distal attachments such as a standard transparent cap or the ST hood short-type (DH-28GR and 29CR; Fujifilm Medical Co., Tokyo, Japan) are useful for colorectal ESD. A transparent cap is usually attached at the distal end of the endoscope, which make it easy to dissect the submucosal layer with lifting up the lesions. This also can be used as an auxiliary tool for compressing the tissue during bleeding (Fig. 3.3).
Fig. 3.3
(a) A transparent hood (D 201-16403; Olympus, Tokyo). (b) The tip of the colonoscope attached to the transparent hood. (c) Small-caliber transparent (ST) hood
3.5.4 Submucosal Injection Solutions
The maintenance of the sufficient submucosal elevation using injecting hypertonic solutions is essential for the success of the ESD. An ideal submucosal injection solution should be inexpensive, readily available, non-toxic, easy to prepare and inject, and should provide a long-lasting submucosal cushion. The normal saline solution is the most commonly used as the injection solution for conventional EMR. Saline-epinephrine injection has been shown to be an effective method for the complete endoscopic polypectomy, especially in flat or sessile lesions. However, other substances such as sodium hyaluronate, hydroxypropyl methylcellulose and glycerol, have been preferred for ESD procedures because of their ability to create a longer lasting submucosal cushion as a result of their viscous properties. A small amount of Indigo Carmine is also mixed to the submucosal-injecting solution to enhance the lesion and margins. Recently the ready-to-use sodium hyaluronate also commercially available—MucoUp® (Seikagaku Co., Tokyo, Japan) and Endo-ease (Unimed Co., Seoul, Korea).
3.5.5 CO2 Insufflation Systems
The use of carbon dioxide (CO2) gas is usually recommended in colorectal ESD. The CO2 insufflation into the colonic lumen has been proven effective to let the patient stand the long ESD procedure and to reduce the risk of pneumoperitoneum in cases of perforation and other complications. Operators should pay always attention to abdominal distension due to over-insufflation of the gas during ESD procedures.